MarketInOut Stock Screener Log In | Sign Up

PsyRX CNS Bio-Tech Ltd

TLV • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/26/2026
PsyRX CNS Bio-Tech Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTLV
Market Capitalization6.83 mln
Float0.40 mln

Piotroski F-Score

3 / 9
Below average

Relative Strength

6 / 100
Severely lagging

ROE

-1,192
Deeply negative

ROA

-297
Deeply negative

Business Description

Founded in 2019 and headquartered in Rishon LeZion, Israel, this company focuses on creating medical and wellness products derived from cannabinoids. Its offerings span prescription treatments for a range of conditions, tailored cannabinoid solutions for individual needs, and consumer products such as CBD skincare and dietary supplements.

Key Fundamentals

EPS-3.51
ROE-1,192
ROIC-329
ROA-297
Interest Cover-79.04
EBITDA, mln-7.44
EV / EBITDA-0.38
EV / EBIT-0.38

Quote Details

Last 59.00
Change 0.6 (1.03%)
Open 68.70
Volume 22,463
Turnover 1,325,317
Average Volume 17,549

Financial Ratios

Leverage Ratio1.30
Current Ratio8.13
Price / Book2.36
Price / Tangible Book2.32
Price / Cash Flow22.82
Price / Free Cash Flow0.83

Financial Strength

Piotroski F-Score 3 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -14.37% 1 / 100   
1 Month -19.18% 4 / 100   
2 Months -32.42% 4 / 100   
6 Months -49.18% 4 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog